RXRX
Recursion Leads the Charge: Decoding Biology to Revolutionize Biopharma
At Recursion's recent [Learnings] Call, Co-Founder and CEO Chris Gibson welcomed investors and analysts to share exciting updates on the company's progress in decoding biology to change the way drugs are discovered and developed. As a leader in this field, Recursion is at the frontier of